抄録
Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment While this is a rare complication of infliximab, early diagnosis and successful management are essential.
本文言語 | 英語 |
---|---|
ページ(範囲) | 1535-1539 |
ページ数 | 5 |
ジャーナル | Journal of Japanese Society of Gastroenterology |
巻 | 108 |
号 | 9 |
出版ステータス | 出版済み - 2011/09 |
ASJC Scopus 主題領域
- 消化器病学